Pregnancy and malignant hyperthermia.
Johnson
C
C
D002170:Canada / Q000453:epidemiology; D003620:Dantrolene / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008305:Malignant Hyperthermia / Q000453:epidemiology* / Q000517:prevention & control; D011247:Pregnancy; D011248:Pregnancy Complications / Q000453:epidemiology*; D006113:United Kingdom / Q000453:epidemiology; D014481:United States / Q000453:epidemiology
D003620:Dantrolene